HVM
VRTX icon

Harvest Volatility Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Harvest Volatility Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,937
Closed -$2.79M – 120
2023
Q2 		$2.79M Sell
7,937
-1,299
-14% -$438K 0.56% 32
2023
Q1 		$2.88M Sell
9,236
-1,598
-15% -$479K 0.58% 34
2022
Q4 		$3.13M Sell
10,834
-2,767
-20% -$843K 0.63% 34
2022
Q3 		$3.98M Sell
13,601
-240
-2% -$69.1K 0.69% 30
2022
Q2 		$3.9M Sell
13,841
-1,666
-11% -$446K 0.63% 33
2022
Q1 		$4.05M Buy
15,507
+15,491
+96,819% +$3.68M 0.46% 39
2021
Q4 		$3.41K Sell
16
-11,927
-100% -$2.32M ﹤0.01% 66
2021
Q3 		$2.17M Buy
11,943
+4,518
+61% +$882K 0.1% 68
2021
Q2 		$1.5M Buy
7,425
+1,784
+32% +$373K 0.12% 60
2021
Q1 		$1.21M Buy
5,641
+2,155
+62% +$473K 0.11% 54
2020
Q4 		$824K Buy
+3,486
New +$800K 0.1% 56

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Volatility Management's VRTX Position: Q3 2023 in Review

Harvest Volatility Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 7,937 shares — an estimated $2.79M sold.

Harvest Volatility Management first reported a position in VRTX in Q4 2020 and held it in 11 quarters. The position peaked at $4.05M in Q1 2022. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Harvest Volatility Management reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Harvest Volatility Management sold 7,937 Vertex Pharmaceuticals shares in Q3 2023, an estimated $2.79M.
  • Harvest Volatility Management first reported a position in Vertex Pharmaceuticals in Q4 2020 and held it in 11 quarters.
  • Harvest Volatility Management's Vertex Pharmaceuticals position peaked at $4.05M in Q1 2022.
  • 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Harvest Volatility Management's 13F filing for Q3 2023, filed 7 Nov 2023.